A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD
Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA‐approved pharmacological therapies for NAFLD, and lifestyle interventions, including...
Gespeichert in:
Veröffentlicht in: | Obesity (Silver Spring, Md.) Md.), 2020-10, Vol.28 (10), p.1843-1852 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1852 |
---|---|
container_issue | 10 |
container_start_page | 1843 |
container_title | Obesity (Silver Spring, Md.) |
container_volume | 28 |
creator | Moore, Mary P. Cunningham, Rory P. Dashek, Ryan J. Mucinski, Justine M. Rector, R. Scott |
description | Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA‐approved pharmacological therapies for NAFLD, and lifestyle interventions, including weight loss and exercise, remain the cornerstones for treatment. Manipulating diet composition and eating patterns may be a sustainable approach to NAFLD treatment. Dietary strategies including Paleolithic, ketogenic, Mediterranean, high‐protein, plant‐based, low‐carbohydrate, and intermittent fasting diets have become increasingly popular because of their purported benefits on metabolic disease. This review highlights what is currently known about these popular dietary approaches in the management of NAFLD in clinical populations with mechanistic insight from animal studies. It also identifies key knowledge gaps to better inform future preclinical and clinical studies aimed at the treatment of NAFLD. |
doi_str_mv | 10.1002/oby.22964 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7511422</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2446727991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4434-d4408e5cd457e54dafe02cab7006abb7dd336ff271aea131319db580b1cede8f3</originalsourceid><addsrcrecordid>eNp1kV1LwzAUhoMofkwv_AMS8EYv5vLVpr1R5uZUHE5QQa9C2pxqpWtm0k32741OhwqSixOSh4f38CK0S8kRJYR1bDY_YiyNxQrapCknbcnTh9XlPaEbaMv7F0JETCK6jjY4S1IuongTXXXxQBvcWBumO8H9Ehrt5vi2cbqBpxI8LqzDzTPgGwczqJvS1ljXBt850M04PGBb4OvuYNjfRmuFrjzsfM0Wuh-c3fUu2sPR-WWvO2znQnDRNkKQBKLciEhCJIwugLBcZ5KQWGeZNIbzuCiYpBo05eGkJosSktEcDCQFb6HjhXcyzcZg8pDB6UpNXDkO0ZXVpfr9U5fP6snOlIwoFYwFwcGXwNnXKfhGjUufQ1XpGuzUKxYSxrHkPAno_h_0xU5dHdb7oGLJZJrSQB0uqNxZ7x0UyzCUqI-KVKhIfVYU2L2f6ZfkdycB6CyAt7KC-f8mNTp9XCjfASJDmog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2446727991</pqid></control><display><type>article</type><title>A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD</title><source>MEDLINE</source><source>Wiley Free Archive</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Moore, Mary P. ; Cunningham, Rory P. ; Dashek, Ryan J. ; Mucinski, Justine M. ; Rector, R. Scott</creator><creatorcontrib>Moore, Mary P. ; Cunningham, Rory P. ; Dashek, Ryan J. ; Mucinski, Justine M. ; Rector, R. Scott</creatorcontrib><description>Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA‐approved pharmacological therapies for NAFLD, and lifestyle interventions, including weight loss and exercise, remain the cornerstones for treatment. Manipulating diet composition and eating patterns may be a sustainable approach to NAFLD treatment. Dietary strategies including Paleolithic, ketogenic, Mediterranean, high‐protein, plant‐based, low‐carbohydrate, and intermittent fasting diets have become increasingly popular because of their purported benefits on metabolic disease. This review highlights what is currently known about these popular dietary approaches in the management of NAFLD in clinical populations with mechanistic insight from animal studies. It also identifies key knowledge gaps to better inform future preclinical and clinical studies aimed at the treatment of NAFLD.</description><identifier>ISSN: 1930-7381</identifier><identifier>EISSN: 1930-739X</identifier><identifier>DOI: 10.1002/oby.22964</identifier><identifier>PMID: 32893456</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Biopsy ; Carbohydrates ; Cytokines ; Diabetes ; Diet ; Disease prevention ; Drug therapy ; Exercise ; Fatty acids ; Fitness training programs ; Gastrointestinal surgery ; Humans ; Inflammation ; Insulin resistance ; Lifestyles ; Liver diseases ; Metabolism ; Non-alcoholic Fatty Liver Disease - diet therapy ; Non-alcoholic Fatty Liver Disease - physiopathology ; Non-alcoholic Fatty Liver Disease - prevention & control ; Obesity ; Oxidative stress ; Paleolithic ; Pathophysiology ; Popularity ; Weight control</subject><ispartof>Obesity (Silver Spring, Md.), 2020-10, Vol.28 (10), p.1843-1852</ispartof><rights>2020 The Obesity Society.</rights><rights>Copyright Blackwell Publishing Ltd. Oct 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4434-d4408e5cd457e54dafe02cab7006abb7dd336ff271aea131319db580b1cede8f3</citedby><cites>FETCH-LOGICAL-c4434-d4408e5cd457e54dafe02cab7006abb7dd336ff271aea131319db580b1cede8f3</cites><orcidid>0000-0003-4432-6638 ; 0000-0002-6365-7718 ; 0000-0001-9908-7123</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Foby.22964$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Foby.22964$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,777,781,882,1412,1428,27905,27906,45555,45556,46390,46814</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32893456$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moore, Mary P.</creatorcontrib><creatorcontrib>Cunningham, Rory P.</creatorcontrib><creatorcontrib>Dashek, Ryan J.</creatorcontrib><creatorcontrib>Mucinski, Justine M.</creatorcontrib><creatorcontrib>Rector, R. Scott</creatorcontrib><title>A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD</title><title>Obesity (Silver Spring, Md.)</title><addtitle>Obesity (Silver Spring)</addtitle><description>Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA‐approved pharmacological therapies for NAFLD, and lifestyle interventions, including weight loss and exercise, remain the cornerstones for treatment. Manipulating diet composition and eating patterns may be a sustainable approach to NAFLD treatment. Dietary strategies including Paleolithic, ketogenic, Mediterranean, high‐protein, plant‐based, low‐carbohydrate, and intermittent fasting diets have become increasingly popular because of their purported benefits on metabolic disease. This review highlights what is currently known about these popular dietary approaches in the management of NAFLD in clinical populations with mechanistic insight from animal studies. It also identifies key knowledge gaps to better inform future preclinical and clinical studies aimed at the treatment of NAFLD.</description><subject>Biopsy</subject><subject>Carbohydrates</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Diet</subject><subject>Disease prevention</subject><subject>Drug therapy</subject><subject>Exercise</subject><subject>Fatty acids</subject><subject>Fitness training programs</subject><subject>Gastrointestinal surgery</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Insulin resistance</subject><subject>Lifestyles</subject><subject>Liver diseases</subject><subject>Metabolism</subject><subject>Non-alcoholic Fatty Liver Disease - diet therapy</subject><subject>Non-alcoholic Fatty Liver Disease - physiopathology</subject><subject>Non-alcoholic Fatty Liver Disease - prevention & control</subject><subject>Obesity</subject><subject>Oxidative stress</subject><subject>Paleolithic</subject><subject>Pathophysiology</subject><subject>Popularity</subject><subject>Weight control</subject><issn>1930-7381</issn><issn>1930-739X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kV1LwzAUhoMofkwv_AMS8EYv5vLVpr1R5uZUHE5QQa9C2pxqpWtm0k32741OhwqSixOSh4f38CK0S8kRJYR1bDY_YiyNxQrapCknbcnTh9XlPaEbaMv7F0JETCK6jjY4S1IuongTXXXxQBvcWBumO8H9Ehrt5vi2cbqBpxI8LqzDzTPgGwczqJvS1ljXBt850M04PGBb4OvuYNjfRmuFrjzsfM0Wuh-c3fUu2sPR-WWvO2znQnDRNkKQBKLciEhCJIwugLBcZ5KQWGeZNIbzuCiYpBo05eGkJosSktEcDCQFb6HjhXcyzcZg8pDB6UpNXDkO0ZXVpfr9U5fP6snOlIwoFYwFwcGXwNnXKfhGjUufQ1XpGuzUKxYSxrHkPAno_h_0xU5dHdb7oGLJZJrSQB0uqNxZ7x0UyzCUqI-KVKhIfVYU2L2f6ZfkdycB6CyAt7KC-f8mNTp9XCjfASJDmog</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Moore, Mary P.</creator><creator>Cunningham, Rory P.</creator><creator>Dashek, Ryan J.</creator><creator>Mucinski, Justine M.</creator><creator>Rector, R. Scott</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4432-6638</orcidid><orcidid>https://orcid.org/0000-0002-6365-7718</orcidid><orcidid>https://orcid.org/0000-0001-9908-7123</orcidid></search><sort><creationdate>202010</creationdate><title>A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD</title><author>Moore, Mary P. ; Cunningham, Rory P. ; Dashek, Ryan J. ; Mucinski, Justine M. ; Rector, R. Scott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4434-d4408e5cd457e54dafe02cab7006abb7dd336ff271aea131319db580b1cede8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biopsy</topic><topic>Carbohydrates</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Diet</topic><topic>Disease prevention</topic><topic>Drug therapy</topic><topic>Exercise</topic><topic>Fatty acids</topic><topic>Fitness training programs</topic><topic>Gastrointestinal surgery</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Insulin resistance</topic><topic>Lifestyles</topic><topic>Liver diseases</topic><topic>Metabolism</topic><topic>Non-alcoholic Fatty Liver Disease - diet therapy</topic><topic>Non-alcoholic Fatty Liver Disease - physiopathology</topic><topic>Non-alcoholic Fatty Liver Disease - prevention & control</topic><topic>Obesity</topic><topic>Oxidative stress</topic><topic>Paleolithic</topic><topic>Pathophysiology</topic><topic>Popularity</topic><topic>Weight control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moore, Mary P.</creatorcontrib><creatorcontrib>Cunningham, Rory P.</creatorcontrib><creatorcontrib>Dashek, Ryan J.</creatorcontrib><creatorcontrib>Mucinski, Justine M.</creatorcontrib><creatorcontrib>Rector, R. Scott</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Obesity (Silver Spring, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moore, Mary P.</au><au>Cunningham, Rory P.</au><au>Dashek, Ryan J.</au><au>Mucinski, Justine M.</au><au>Rector, R. Scott</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD</atitle><jtitle>Obesity (Silver Spring, Md.)</jtitle><addtitle>Obesity (Silver Spring)</addtitle><date>2020-10</date><risdate>2020</risdate><volume>28</volume><issue>10</issue><spage>1843</spage><epage>1852</epage><pages>1843-1852</pages><issn>1930-7381</issn><eissn>1930-739X</eissn><abstract>Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA‐approved pharmacological therapies for NAFLD, and lifestyle interventions, including weight loss and exercise, remain the cornerstones for treatment. Manipulating diet composition and eating patterns may be a sustainable approach to NAFLD treatment. Dietary strategies including Paleolithic, ketogenic, Mediterranean, high‐protein, plant‐based, low‐carbohydrate, and intermittent fasting diets have become increasingly popular because of their purported benefits on metabolic disease. This review highlights what is currently known about these popular dietary approaches in the management of NAFLD in clinical populations with mechanistic insight from animal studies. It also identifies key knowledge gaps to better inform future preclinical and clinical studies aimed at the treatment of NAFLD.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>32893456</pmid><doi>10.1002/oby.22964</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-4432-6638</orcidid><orcidid>https://orcid.org/0000-0002-6365-7718</orcidid><orcidid>https://orcid.org/0000-0001-9908-7123</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1930-7381 |
ispartof | Obesity (Silver Spring, Md.), 2020-10, Vol.28 (10), p.1843-1852 |
issn | 1930-7381 1930-739X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7511422 |
source | MEDLINE; Wiley Free Archive; Wiley Online Library Journals Frontfile Complete |
subjects | Biopsy Carbohydrates Cytokines Diabetes Diet Disease prevention Drug therapy Exercise Fatty acids Fitness training programs Gastrointestinal surgery Humans Inflammation Insulin resistance Lifestyles Liver diseases Metabolism Non-alcoholic Fatty Liver Disease - diet therapy Non-alcoholic Fatty Liver Disease - physiopathology Non-alcoholic Fatty Liver Disease - prevention & control Obesity Oxidative stress Paleolithic Pathophysiology Popularity Weight control |
title | A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T18%3A57%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Fad%20too%20Far?%20Dietary%20Strategies%20for%20the%20Prevention%20and%20Treatment%20of%20NAFLD&rft.jtitle=Obesity%20(Silver%20Spring,%20Md.)&rft.au=Moore,%20Mary%20P.&rft.date=2020-10&rft.volume=28&rft.issue=10&rft.spage=1843&rft.epage=1852&rft.pages=1843-1852&rft.issn=1930-7381&rft.eissn=1930-739X&rft_id=info:doi/10.1002/oby.22964&rft_dat=%3Cproquest_pubme%3E2446727991%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2446727991&rft_id=info:pmid/32893456&rfr_iscdi=true |